Condition 1: Attention-deficit hyperactivity disorders. Condition 2: Generalized anxiety disorder. Attention-deficit hyperactivity disorders Generalized anxiety disorder
Conditions
Interventions
Intervention 1: Intervention group: The first intervention group receives methylphenidate (Ritalin) and buspirone. Methylphenidate (Ritalin) is initially given at a dose of 0.3 mg per kilogram of body
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 17 Years
Inclusion criteria
Inclusion criteria: Consent to participate in the study by parents Age 6 to 17 years Having ADHD and anxiety at the same time, based on DSM-5 criteria and the opinion of a pediatric psychiatrist
Exclusion criteria
Exclusion criteria: Presence of psychotic spectrum disorders Presence of intellectual disability Presence of autism spectrum disorders Severe physical illnesses
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms of attention deficit hyperactivity disorder. Timepoint: At the beginning of the study and 8 weeks after starting the drug. Method of measurement: Conners parent rating scale questionnaire.;Anxiety symptoms. Timepoint: At the beginning of the study and 8 weeks after starting the drug. Method of measurement: The Spence Children's Anxiety Scale – Parent. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehran Hajiloo
Hamedan University of Medical Sciences
Outcome results
None listed